Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of p16 expression on surgical management of malignant melanoma and pancreatic carcinoma.

American journal of surgery - 1 Jan 1999

Bullock G J, Green J L, Baron P L

Abstract excerpt

BACKGROUND: Recent advances in molecular oncology have provided explanations at the DNA level for the malignant transformation and metastatic potential of various cancers. Malignant melanoma and pancreatic cancer may be classified together in both these cancers exhibit mutations in, or loss of, the cell-cycle inhibitory gene, p16. This paper reviews the current literature on p16 expression in melanoma and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Melanoma

Share to Pancreatic Neoplasms

Share to Prognosis

Share to Skin Neoplasms

Source

Identifiers

PMID: 10037301
DOI: 10.1016/s0002-9610(98)00297-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of p16 expression on surgical management of malignant melanoma and pancreatic carcinoma.PMID 10037301Read ↗

Novel presentation of a familial pancreatic cancer syndrome.Semantic proximity Read ↗

Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.Semantic proximity Read ↗

Pancreatic carcinoma surveillance in patients with familial melanoma.Semantic proximity Read ↗

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.Semantic proximity Read ↗

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.Semantic proximity Read ↗

A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition.Semantic proximity Read ↗

CDKN2A germline mutations in familial pancreatic cancer.Semantic proximity Read ↗

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.Semantic proximity Read ↗

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 p16LeidenSemantic proximity Read ↗

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)Semantic proximity Read ↗

Familial head and neck cancer: molecular analysis of a new clinical entity.Semantic proximity Read ↗

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.